Table 4.
Perceived priority for the execution of endoscopic procedures during the 2019 and 2020 periods.
| Perceived priority | 2019 | 2020 |
|---|---|---|
| IBD: new diagnosis, n (%) | ||
| 1 | 0 (0) | 0 (0) |
| 2 | 0 (0) | 0 (0) |
| 3 | 0 (0) | 0 (0) |
| 4 | 0 (0) | 3 (12.5) |
| 5 | 23 (95.8) | 20 (83.3) |
| Missing | (4.2) | 1 (4.2) |
| IBD: endoscopic re-assessment, n (%) | ||
| 1 | 0 (0) | 2 (8.3) |
| 2 | 2 (8.3) | 7 (29.2) |
| 3 | 7 (29.2) | 9 (37.5) |
| 4 | 11 (45.8) | 4 (16.7) |
| 5 | 4 (16.7) | 2 (8.3) |
| Celiac Disease, n (%) | ||
| 1 | 0 (0) | 0 (0) |
| 2 | 1 (4.2) | 6 (25.0) |
| 3 | 8 (33.3) | 6 (25.0) |
| 4 | 11 (45.8) | 9 (37.5) |
| 5 | 4 (16.7) | 2 (8.3) |
| Missing | 1 (4.2) | 1 (4.2) |
| EoE: new diagnosis, n (%) | ||
| 1 | 0 (0) | 0 (0) |
| 2 | 0 (0) | 0 (0) |
| 3 | 1 (4.2) | 3 (12.5) |
| 4 | 6 (25.0) | 10 (41.7) |
| 5 | 16 (66.7) | 10 (41.7) |
| Missing | 1 (4.2) | 1 (4.2) |
| EoE: endoscopic re-assessment, n (%) | ||
| 1 | 0 (0) | 9 (37.5) |
| 2 | 3 (12.5) | 5 (20.8) |
| 3 | 11 (45.8) | 3 (12.5) |
| 4 | 7 (29.2) | 6 (25) |
| 5 | 2 (8.3) | 0 (0) |
| Missing | 1 (4.2) | 1 (4.2) |
| GERD: new diagnosis, n (%) | ||
| 1 | 1 (4.2) | 4 (16.7) |
| 2 | 2 (8.3) | 7 (29.2) |
| 3 | 12 (50) | 8 (33.3) |
| 4 | 9 (37.5) | 4 (16.7) |
| 5 | 0 (0) | 0 (0) |
| Missing | 0 (0) | 1 (4.2) |
| GERD: re-assessment, n (%) | ||
| 1 | 6 (25.0) | 16 (66.7) |
| 2 | 9 (37.5) | 3 (12.5) |
| 3 | 5 (20.8) | 3 (12.5) |
| 4 | 4 (16.7) | 1 (4.2) |
| 5 | 0 (0) | 0 (0) |
| Missing | 0 (0) | 1 (4.2) |
| FGID, n (%) | ||
| 1 | 1 (4.2) | 16 (66.7) |
| 2 | 6 (25) | 6 (25.0) |
| 3 | 6 (25) | 1 (4.2) |
| 4 | 9 (37.5) | 0 (0) |
| 5 | 1 (4.2) | 0 (0) |
| Missing | 1 (4.2) | 1 (4.2) |